NDC 15631-2320

RUTA GRAV

Ruta Grav

RUTA GRAV is a Topical Gel in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Ruta Graveolens Flowering Top.

Product ID15631-2320_a070c051-af1a-4805-8828-f81134e035db
NDC15631-2320
Product TypeHuman Otc Drug
Proprietary NameRUTA GRAV
Generic NameRuta Grav
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2016-04-26
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameRUTA GRAVEOLENS FLOWERING TOP
Active Ingredient Strength1 [hp_X]/g
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-2320-0

1 CONTAINER in 1 CONTAINER (15631-2320-0) > 50 g in 1 CONTAINER
Marketing Start Date2016-04-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-2320-0 [15631232000]

RUTA GRAV GEL
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-04-26
Inactivation Date2020-01-31

NDC 15631-2320-3 [15631232003]

RUTA GRAV GEL
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-04-26
Inactivation Date2020-01-31

NDC 15631-2320-2 [15631232002]

RUTA GRAV GEL
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-04-26
Inactivation Date2020-01-31

NDC 15631-2320-1 [15631232001]

RUTA GRAV GEL
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-04-26
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
RUTA GRAVEOLENS FLOWERING TOP1 [hp_X]/g

OpenFDA Data

SPL SET ID:1654d4d8-98a3-46bf-b8b4-772ec11054a1
Manufacturer
UNII

NDC Crossover Matching brand name "RUTA GRAV" or generic name "Ruta Grav"

NDCBrand NameGeneric Name
15631-2320RUTA GRAVRUTA GRAV
54973-0625RUTA GRAVruta graveolens flowering top
54973-2925RUTA GRAVruta graveolens flowering top
0360-0332RUTA GRAVEOLENSRUTA GRAV
0360-0333RUTA GRAVEOLENSRUTA GRAV

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.